SWOT Analysis for RPG Life Sciences Ltd. - Weakness

Add SWOT widget to your site/app

MACD Crossover Above Signal Line

Companies with no Debt

Companies with current TTM PE Ratio less than 3 Year, 5 Year and 10 Year PE

Newly Affordable Stocks with Good Financials and Durability (subscription)

Undervalued Growth Stocks

Jim Slater's Zulu Principle (Discover Growth Stocks)

Consistent Highest Return Stocks over Five Years

Mid-range Performer (DVM)

Stocks with Consistent Share Price Growth (subscription)

Companies with high TTM EPS Growth

Strong Annual EPS Growth

Strong QoQ EPS Growth in recent results

Annual Profit Growth higher than Sector Profit Growth

PEG lower than Industry PEG

Relative Outperformance versus Industry over 1 Week

Effectively using Shareholders fund - Return on equity (ROE) improving since last 2 year

Efficient in managing Assets to generate Profits - ROA improving since last 2 year

Growth in Net Profit with increasing Profit Margin (QoQ)

Growth in Quarterly Net Profit with increasing Profit Margin (YoY)

Increasing profits every quarter for the past 2 quarters

Company able to generate Net Cash - Improving Net Cash Flow for last 2 years

Annual Net Profits improving for last 2 years

Book Value per share Improving for last 2 years

Companies with Zero Promoter Pledge

Stocks in uptrend most likely to cross above SMA-200 soon

MACD crossed above signal line previous end of day

Bearish Stocks - Stocks with Medium to Low Trendlyne Momentum Score

Stocks with Expensive Valuations according to the Trendlyne Valuation Score

Increasing Trend in Non-Core Income

Top Losers

Stocks Underperforming their Industry Price Change in the Quarter

FII / FPI or Institutions increasing their shareholding

MFs increased their shareholding last quarter

Rising Delivery Percentage Compared to Prev Day

Bullish or Bearish Candlestick Strength - Indices

Dragonfly Doji (Bullish Reversal)